Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients
Abstract Background Pancreatic cancer (PC) is a malignancy with a poor prognosis and high mortality. Surgical resection is the only “curative” treatment. However, only a minority of patients with PC can obtain surgery. Improving the overall survival (OS) rate of patients with PC is still a major cha...
Main Authors: | Wei Li, Tiandong Li, Chenguang Sun, Yimeng Du, Linna Chen, Chunyan Du, Jianxiang Shi, Weijie Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-022-00467-8 |
Similar Items
-
Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer
by: Masanori Oshi, et al.
Published: (2021-03-01) -
KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma
by: Li Y, et al.
Published: (2021-06-01) -
Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer
by: Qi-Shun Geng, et al.
Published: (2022-01-01) -
Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic analysis and in vitro experiments
by: Xiaohua Lei, et al.
Published: (2021-09-01) -
Label-free proteomics to identify keratins and keratin-associated proteins and their effects on the fleece traits of Inner Mongolia Cashmere Goats
by: Chongyan Zhang, et al.
Published: (2023-01-01)